| Financial Year |
March 31 2023 |
| Monetary Funds |
7,355,523,130.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,705,449,841.50 |
| Advances to Suppliers |
106,992.85 |
| Other Receivables |
661,014,430.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,456,202.68 |
| Total Current Assets |
9,834,550,598.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
222,531,118,677.56 |
| Under-construction Projects |
85,873,148.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,702,972,388.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
444,083.34 |
| Other Non-Current Assets |
824,237,473.95 |
| Sub-Total of Non-Current Assets |
281,177,734,683.29 |
| Total Assets |
291,012,285,281.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
989,331,269.93 |
| Accounts Received In Advance |
22,857,142.80 |
| Employee Compensation Payable |
5,010,875.73 |
| Taxes Payable |
1,001,177,147.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,004,888,095.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,793,089,979.08 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
10,034,539,043.83 |
| Long-term Loans |
70,864,464,880.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
85,260,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
258,897,742.82 |
| Other Non-Current Liabilities |
282,240,000.00 |
| Sub-Total of Non-Current Liabilities |
71,492,638,956.49 |
| Total Liabilities |
81,527,178,000.32 |
| Paid-In Capital(Or Share Stock) |
49,106,484,611.00 |
| Capital Surplus |
122,596,155,858.47 |
| Surplus Reserve |
5,379,657,546.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,985,042,880.11 |
| Minority Stockholder's Interest |
23,199,534,048.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
186,285,573,232.73 |
| Owner's Equity（Stockholder's Equity） |
209,485,107,281.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
291,012,285,281.79 |
